Skip to content
Clinical Trials – home
Research site

University Of Tartu

Estonia L. Puusepa Tn 8, 50406 Tartu, Estonia

  • 1 trial recruiting
  • Acute myocardial infarction · Metastatic malignant melanoma
  • Adult patients

About Specializations

University Of Tartu in Tartu, Estonia specialises in clinical trials of conditions such as Acute myocardial infarction, Metastatic malignant melanoma, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The Department of Cardiology at University of Tartu focuses on cardiovascular diseases, especially acute myocardial infarction (AMI). Ongoing trials evaluate self‑administered treatments to improve early symptom management and lower the risk of recurrent heart attacks.

  • Self‑administered thrombin receptor antagonists
  • Rapid response protocols for AMI
  • Risk stratification in recurrent cardiac events

The site conducts two investigator‑led studies with commercial collaboration, aiming to bring faster, patient‑controlled therapies to the clinic.

Oncology & Immunotherapy

Research at University of Tartu also targets neoplasms, concentrating on unresectable or metastatic melanoma. Current investigations compare novel biologic agents to established checkpoint inhibitors to enhance treatment effectiveness for patients who have not received prior systemic therapy.

  • Bispecific antibody development
  • Checkpoint inhibitor combination strategies
  • Biomarker‑driven melanoma therapies

Supported by a commercial partner, the two trials aim to expand therapeutic options and improve survival outcomes in advanced melanoma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
L. Puusepa Tn 850406 TartuEstonia
Recruiting now
1 trial
Conditions studied
2

More sites in TartuEstonia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.